The Photobiomics Research Institute was formed
(1) to conduct, supervise, support, promote, promulgate and assist the widest possible research into photobiomics technologies, therapies, protocols, devices and any other clinical or therapeutic photobiomic treatments that will promote human health, treat or improve diseases, help patients manage all possible diseases including, but not limited to: neurodegenerative diseases, metabolic diseases, chronic pain and any and all other diseases.; and
(2) to promote public education about and understanding of photobiomodulation, and to pursue such other charitable objects as may be determined by the members of the association from time to time.
Peter is an experienced lawyer, company advisor and director with a strong track record in leading charities and in innovative med/bio-technologies. Peter has advised governments on how to develop many medical technologies out of research institutes and universities, raised capital, and led senior technology management teams. He received a lifetime achievement award for corporate governance from the AICD, was an APEC Summit (Shanghai) keynote speaker on Medtech investing in Asia-Pacific, a former Garvan Institute of Medical Research Commercialisation Director and graduated from Harvard College and Boston University Law School.
Renal Clinician at Royal Northshore Hospital and Kolling Institute
Former Chair Northshore Area Local Health District
Inaugural Chair of the NSW Agency for Clinical Innovation
Immediate Past Chair of the Clinical Excellence Commission
Chairman Bureau of Health Information NSW Department of Health.
Phillip is a director and CEO of Race Oncology. Phil has over 30 years experience working in Asia Pacific (AP) markets with Johnson & Johnson, where he was Managing Director for Australian Consumer Health Producs and other major roles throughout Asia Pacific. He is an experienced Board Director with a diverse background across corporate development, strategy, financial performance, marketing and governance. He’s a Business graduate from Monash University, has completed post graduate studies at the University of Virginia Darden Business school and is a Graduate of the Australian Institute of Company Directors.
Currently research director for the health faculty at Torrens University and was appointed Director for the Centre for Healthy Futures. Professor McLachlan was Director for Research at the UNSW Rural Clinical School and an Associate Professor for eight years. In this capacity as research director Professor McLachlan worked closely with his school, rural hospitals, and regional communities to build up a clinical trials objective. Professor McLachlan was a founder and active committee executive member of the Mid North Coast Collaborative Research Hub overseen by the Mid North Coast Local health district that supported bi-directional research with universities and the hospital network for trials and clinical audits. Professor McLachlan was a long serving committee member of the FRAME executive survey committee that surveys the career destinations of medical students across 17 medical schools for the Commonwealth funded Rural Clinical Schools program, demonstrating a research agenda at the National level for rural health education.
Professor Stone received a Bachelor of Medical Science from the University of Sydney in 1963 and a PhD in 1966. Thereafter he spent many years at prestigious medical institutions overseas until he moved to the School of Anatomy at the University of New South Wales (UNSW) initially as a senior lecturer, then as an associate professor (1978–85). He became head of the school and took up a Personal Chair in Anatomy in 1985. During his years at the UNSW, Stone's research interests shifted from the study of parallel processing to the development of the brain. His next appointment was as Challis Professor of Anatomy at the University of Sydney (1987–2003). Here he worked on the interaction of neuroglial cells during the stresses of birth, particularly focusing on types of blindness that result from the degeneration of photoreceptor cells. Stone was appointed Director of the Research School of Biological Sciences at the Australian National University (ANU) in 2003. At the ANU his research concerns the stability and degeneration of the central nervous system, including dementia and a group of inherited eye diseases that affect the retina.
Copyright © 2022 Photobiomics Research Institute - All Rights Reserved.